Proteintech Group Inc. opens new Singapore office
Retrieved on:
Tuesday, July 5, 2022
Health, Genetics, Other Science, General Health, Research, Science, Biotechnology, Single-domain antibody, Singapore Science Park, CEO, Biotechnology, Protein, Research, International Business Park, ISO9001, Lion, Tuas Biomedical Park, Cytokine, ISO13485, Publication, Proteome, Hay Group Global R&D Center for Strategy Execution, Antibody, Multimedia, Retail, Fine chemical
Proteintech, the benchmark in antibodies, Nanobodies, and cytokines & growth factors, today announces the opening of its new Singapore office and warehouse at The Strategy, 2 International Business Park.
Key Points:
- Proteintech, the benchmark in antibodies, Nanobodies, and cytokines & growth factors, today announces the opening of its new Singapore office and warehouse at The Strategy, 2 International Business Park.
- View the full release here: https://www.businesswire.com/news/home/20220705005683/en/
The new Proteintech Singapore team (Photo: Business Wire)
With its new office, Proteintech can better serve and support customers in the fast-growing APAC market. - Establishing the new office in Singapore puts dedicated resources to the fast-growing APAC countries.
- Proteintech Group Inc., founded in 2002, is a leading manufacturer of antibodies, proteins, Nanobodies, and immunoassays.